Malignant Bone Neoplasm — Trials

Malignant Bone Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

152 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 38
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 31.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03468075	Gemcitabine Plus Ascorbate for Sarcoma in Adults	terminated	Phase 2	10	Mohammed Milhem, MBBSOTHER	1	Dec 10, 2020	clinicaltrials
NCT01313884	Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma	terminated	Phase 2	3	Stanford UniversityOTHER	1	Nov 24, 2017	clinicaltrials
NCT00127387